Mode
Text Size
Log in / Sign up
Phase 2 N=65 Randomized Prevention

Effect of a Unique Web-based Behaviour Change Program on Weight Loss and Cardiovascular Risk Factors

Obesity

Enrolled (actual)
65
Serious AEs
0.0%
Results posted
May 2023
Primary outcome: Primary: Weight Loss Kg — -0.53; -4.37 kg

Study Design & Population

Study type
Interventional
Phase
Phase 2
Interventions
Web-based program (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Queen's University, Belfast
Primary completion
Mar 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Weight Loss Kg
-0.53; -4.37
SECONDARY
Weight Loss
SECONDARY
Physical Activity
SECONDARY
Blood Pressure (Seated, Systolic and Diastolic mmHg)
SECONDARY
Biochemical Markers of CVD Risk
SECONDARY
Dietary Intake
SECONDARY
Pulse Wave Analysis
SECONDARY
Quality of Life
SECONDARY
Sleep Quality
SECONDARY
Self-esteem
SECONDARY
Self-efficacy
SECONDARY
Depression

Summary

Web- or internet-based programs have the potential to induce and, possibly, help to sustain, significant lifestyle modification. This study will evaluate the effect of a unique interactive web-based behaviour change program on weight loss and cardiovascular risk factors in people who are overweight or obese and at high risk of cardiovascular disease.

Eligibility Criteria

Inclusion Criteria

  • Over 18 years old
  • Have regular access to the internet, telephone and have an e-mail address.
  • Body mass index (BMI) greater than 27 and less than 40
  • Sedentary
  • Have one or more of the following risk factors associated with cardiovascular disease: Elevated blood pressure ≥ 140 mm Hg systolic or ≥ 90 mm Hg diastolic; Elevated total cholesterol ≥ 5.0; Type 2 diabetes
  • Be willing to refrain from participating in another behaviour change program for the duration of the study

Exclusion Criteria

  • Major health problems including Type 1 diabetes, established CVD, renal and hepatic disease
  • Psychiatric problems
  • Pregnancy
  • Excessive alcohol consumption
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01472276). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search